Archana Sreenivas
Research Subjects
Archana Sreenivas has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Deepak Kumar Jha
Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, Karnataka, India
1 shared publication
Latest Publications
- Open Access
- 11 March 2025
- Published by IntechOpen
Cell-Free Therapies: Revolutionizing the Approach to Cellular Treatments
Cellular therapies, including hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and non-stem cell-based therapies like CAR-T cells, have gained prominence in therapeutic applications due to their regenerative and immunomodulatory properties. Despite the benefits observed in patients, these therapies are often accompanied by certain disadvantages that limit their clinical use. In contrast, cell-free therapies, such as acellular scaffolds, small molecules, RNA molecules, and MSC-derived factors such as extracellular vesicles (EVs), present a promising alternative for treating a wide range of diseases. These therapies offer several advantages, including minimal immunogenicity, defined composition, cost-effectiveness, and ease of storage for extended periods. This chapter will provide a comprehensive overview of the various cell-free therapeutic approaches in the context of different diseases and explore how these methods can revolutionize treatment, offering a significant advancement over traditional cellular therapies.
- 11 March 2025
- Published by IntechOpen
Open AccessCell-Free Therapies: Revolutionizing the Approach to Cellular Treatments
Cellular therapies, including hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and non-stem cell-based therapies like CAR-T cells, have gained prominence in therapeutic applications due to their regenerative and immunomodulatory properties. Despite the benefits observed in patients, these therapies are often accompanied by certain disadvantages that limit their clinical use. In contrast, cell-free therapies, such as acellular scaffolds, small molecules, RNA molecules, and MSC-derived factors such as extracellular vesicles (EVs), present a promising alternative for treating a wide range of diseases. These therapies offer several advantages, including minimal immunogenicity, defined composition, cost-effectiveness, and ease of storage for extended periods. This chapter will provide a comprehensive overview of the various cell-free therapeutic approaches in the context of different diseases and explore how these methods can revolutionize treatment, offering a significant advancement over traditional cellular therapies.